Unveiling 3 Analyst Insights On Arcturus Therapeutics
Unveiling 3 Analyst Insights On Arcturus Therapeutics
揭示3位分析師對arcturus therapeutics的見解
A comprehensive examination of how financial experts perceive Arcturus Therapeutics is...Providing a diverse range of perspectives from bullish to bearish, 3 analysts have published ratings on Arcturus Therapeutics (NASDAQ:ARCT) in the last three months.
在過去的三個月裏，3位分析師對arcturus therapeutics（納斯達克：ARCT）發佈了從看好到看淡的多元化觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Arcturus Therapeutics, revealing an average target of $65.33, a high estimate of $70.00, and a low estimate of $63.00. This current average reflects an increase of 6.23% from the previous average price target of $61.50.
分析師爲Arcturus Therapeutics設定了12個月的價格目標，展示了平均目標爲65.33美元，高估爲70.00美元，低估爲63.00美元。當前的平均值反映了相較於之前的平均價格目標61.50美元的增長6.23%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
A comprehensive examination of how financial experts perceive Arcturus Therapeutics is...
最近分析師的行動得出了...
登入免費觀看全文
登入/註冊
熱門討論
美聯儲暫停降息，你如何調整持倉？
美聯儲宣布基準利率維持在4.25%—4.50%不變，符合市場預期。你會如何配置資產？
Moo Live
01/30 03:25
FOMC新聞發佈會，2025年1月29日